P2X7 Receptors as a Therapeutic Target in Cerebrovascular Diseases

Bibliographic Details
Title: P2X7 Receptors as a Therapeutic Target in Cerebrovascular Diseases
Authors: Abraham J. Cisneros-Mejorado, Alberto Pérez-Samartín, María Domercq, Rogelio O. Arellano, Miroslav Gottlieb, Friedrich Koch-Nolte, Carlos Matute
Source: Frontiers in Molecular Neuroscience, Vol 13 (2020)
Publisher Information: Frontiers Media S.A., 2020.
Publication Year: 2020
Collection: LCC:Neurosciences. Biological psychiatry. Neuropsychiatry
Subject Terms: ATP, pannexin-1, ischemia, neuron, oligodendrocyte, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571
More Details: Shortage of oxygen and nutrients in the brain induces the release of glutamate and ATP that can cause excitotoxicity and contribute to neuronal and glial damage. Our understanding of the mechanisms of ATP release and toxicity in cerebrovascular diseases is incomplete. This review aims at summarizing current knowledge about the participation of key elements in the ATP-mediated deleterious effects in these pathologies. This includes pannexin-1 hemichannels, calcium homeostasis modulator-1 (CALHM1), purinergic P2X7 receptors, and other intermediaries of CNS injury downstream of ATP release. Available data together with recent pharmacological developments in purinergic signaling may constitute a new opportunity to translate preclinical findings into more effective therapies in cerebrovascular diseases.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1662-5099
Relation: https://www.frontiersin.org/article/10.3389/fnmol.2020.00092/full; https://doaj.org/toc/1662-5099
DOI: 10.3389/fnmol.2020.00092
Access URL: https://doaj.org/article/9660776ba0cc43399a55ce85ed8a997f
Accession Number: edsdoj.9660776ba0cc43399a55ce85ed8a997f
Database: Directory of Open Access Journals
More Details
ISSN:16625099
DOI:10.3389/fnmol.2020.00092
Published in:Frontiers in Molecular Neuroscience
Language:English